Nasal delivery of xylitol
DCFirst Claim
Patent Images
1. A pharmaceutical composition for preventing and/or treating upper respiratory infections in a mammal comprising an active agent consisting essentially of xylitol in combination with a pharmaceutically acceptable carrier suitable for intranasal delivery.
4 Assignments
Litigations
0 Petitions
Accused Products
Abstract
The present invention is a method and pharmaceutical composition for prevention and/or treatment of upper respiratory infections including otitis media by nasal administration of xylitol.
45 Citations
26 Claims
- 1. A pharmaceutical composition for preventing and/or treating upper respiratory infections in a mammal comprising an active agent consisting essentially of xylitol in combination with a pharmaceutically acceptable carrier suitable for intranasal delivery.
- 13. A method of preventing and/or treating upper respiratory infections, in a mammal in need thereof comprising nasally delivering to the mammal an active agent consisting essentially of xylitol in a pharmaceutically acceptable carrier suitable for nasal delivery.
Specification